These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 25797895

  • 1. L-FABP: A novel biomarker of kidney disease.
    Xu Y, Xie Y, Shao X, Ni Z, Mou S.
    Clin Chim Acta; 2015 May 20; 445():85-90. PubMed ID: 25797895
    [Abstract] [Full Text] [Related]

  • 2. Urinary liver fatty acid-binding protein: another novel biomarker of acute kidney injury.
    McMahon BA, Murray PT.
    Kidney Int; 2010 Apr 20; 77(8):657-9. PubMed ID: 20354549
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice.
    Kamijo-Ikemori A, Sugaya T, Sekizuka A, Hirata K, Kimura K.
    Nephrol Dial Transplant; 2009 Mar 20; 24(3):788-800. PubMed ID: 18854419
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Temporal changes in urinary excretion of liver-type fatty acid binding protein (L-FABP) in acute kidney injury model of domestic cats: a preliminary study.
    Katayama M, Miyazaki T, Ohata K, Oikawa T, Kamiie J, Sugaya T, Miyazaki M.
    J Vet Med Sci; 2019 Dec 26; 81(12):1868-1872. PubMed ID: 31645505
    [Abstract] [Full Text] [Related]

  • 8. Urinary liver type fatty acid binding protein in diabetic nephropathy.
    Kamijo-Ikemori A, Sugaya T, Ichikawa D, Hoshino S, Matsui K, Yokoyama T, Yasuda T, Hirata K, Kimura K.
    Clin Chim Acta; 2013 Sep 23; 424():104-8. PubMed ID: 23727660
    [Abstract] [Full Text] [Related]

  • 9. Renal L-type fatty acid--binding protein in acute ischemic injury.
    Yamamoto T, Noiri E, Ono Y, Doi K, Negishi K, Kamijo A, Kimura K, Fujita T, Kinukawa T, Taniguchi H, Nakamura K, Goto M, Shinozaki N, Ohshima S, Sugaya T.
    J Am Soc Nephrol; 2007 Nov 23; 18(11):2894-902. PubMed ID: 17942962
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.
    Matsui K, Kamijo-Ikemorif A, Sugaya T, Yasuda T, Kimura K.
    Am J Pathol; 2011 Mar 23; 178(3):1021-32. PubMed ID: 21356355
    [Abstract] [Full Text] [Related]

  • 16. [L-type fatty acid binding protein (L-FABP) and kidney disease].
    Kamijo-Ikemori A, Sugaya T, Kimura K.
    Rinsho Byori; 2014 Feb 23; 62(2):163-70. PubMed ID: 24800492
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. L-FABP and IL-6 as markers of chronic kidney damage in children after hemolytic uremic syndrome.
    Lipiec K, Adamczyk P, Świętochowska E, Ziora K, Szczepańska M.
    Adv Clin Exp Med; 2018 Jul 23; 27(7):955-962. PubMed ID: 29905409
    [Abstract] [Full Text] [Related]

  • 19. A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure.
    Negishi K, Noiri E, Sugaya T, Li S, Megyesi J, Nagothu K, Portilla D.
    Kidney Int; 2007 Aug 23; 72(3):348-58. PubMed ID: 17495861
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.